PAVmed Inc. Series Z Warrant
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing… Read more
Market Cap & Net Worth: PAVmed Inc. Series Z Warrant (PAVMZ)
PAVmed Inc. Series Z Warrant (NASDAQ:PAVMZ) has a market capitalization of $8.31 ($8.31) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #44526 globally and #14103 in its home market, demonstrating a -72.73% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PAVmed Inc. Series Z Warrant's stock price $0.00 by its total outstanding shares 9235 (9.23K).
PAVmed Inc. Series Z Warrant Market Cap History: 2018 to 2025
PAVmed Inc. Series Z Warrant's market capitalization history from 2018 to 2025. Data shows change from $2.96K to $8.31 (-62.97% CAGR).
PAVmed Inc. Series Z Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PAVmed Inc. Series Z Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
PAVmed Inc. Series Z Warrant's market cap is 0.00 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
PAVmed Inc. Series Z Warrant's market cap is 0.00 times its annual earnings
1.95x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $14.78K | $500.00K | -$50.35 Million | 0.03x | N/A |
| 2022 | $2.03K | $377.00K | -$101.29 Million | 0.01x | N/A |
| 2023 | $1.02K | $2.45 Million | -$64.17 Million | 0.00x | N/A |
| 2024 | $91.43 | $3.00 Million | $39.79 Million | 0.00x | 0.00x |
Competitor Companies of PAVMZ by Market Capitalization
Companies near PAVmed Inc. Series Z Warrant in the global market cap rankings as of March 19, 2026.
Key companies related to PAVmed Inc. Series Z Warrant by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
PAVmed Inc. Series Z Warrant Historical Marketcap From 2018 to 2025
Between 2018 and today, PAVmed Inc. Series Z Warrant's market cap moved from $2.96K to $ 8.31, with a yearly change of -62.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.31 | -90.91% |
| 2024 | $91.43 | -91.00% |
| 2023 | $1.02K | -50.00% |
| 2022 | $2.03K | -86.25% |
| 2021 | $14.78K | +36.75% |
| 2020 | $10.80K | +201.08% |
| 2019 | $3.59K | +21.44% |
| 2018 | $2.96K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of PAVmed Inc. Series Z Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.31 USD |
| MoneyControl | $8.31 USD |
| MarketWatch | $8.31 USD |
| marketcap.company | $8.31 USD |
| Reuters | $8.31 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.